CRISPR/Cas9 Instantaneous Gene Editing Therapy to Intraocular Hypertensive POAG With MYOC Mutation
Clinical trial NCT06465537 · UNKNOWN
Trial details
- NCT number
- NCT06465537
- Sponsor
- Shanghai BDgene Co., Ltd.
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-10
- Primary completion
- 2025-12-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.